These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28292477)

  • 1. Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors' Facility Residents.
    Featherstone T; Eurich DT; Simpson SH
    Value Health; 2017 Mar; 20(3):329-335. PubMed ID: 28292477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    J Gen Intern Med; 2008 Sep; 23(9):1346-53. PubMed ID: 18543044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutoff value of HbA1c for predicting diabetes and prediabetes in a Chinese high risk population aged over 45.
    Zhang R; Wang J; Luo J; Yang X; Yang R; Cai D; Zhang H
    Asia Pac J Clin Nutr; 2015; 24(3):360-6. PubMed ID: 26420175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adults.
    Zhang Y; Hu G; Zhang L; Mayo R; Chen L
    PLoS One; 2015; 10(3):e0120382. PubMed ID: 25790106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative dysglycemia in elective non-diabetic surgical patients: a prospective observational study.
    Yang MH; Jaeger M; Baxter M; VanDenKerkhof E; van Vlymen J
    Can J Anaesth; 2016 Dec; 63(12):1319-1334. PubMed ID: 27699579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.
    Costa B; Barrio F; Piñol JL; Cabré JJ; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O;
    BMC Med; 2013 Feb; 11():45. PubMed ID: 23438147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocytosis and Performance of HbA1c in Detecting Diabetes on an Oxygen-Deficient Plateau: A Population-based Study.
    Ren Q; Lv X; Yang L; Yue J; Luo Y; Zhou L; Meng S; Yang S; Puchi B; Zhou X; Ji L
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31904080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of three diabetes prediction scores in a Spanish cohort: does adding high risk for depression improve the validation of the FINDRISC score (FINDRISC-MOOD)?
    Salinero-Fort M; Mostaza-Prieto JM; Lahoz-Rallo C; Cárdenas-Valladolid J; Iriarte-Campo V; Estirado-Decabo E; Garcia-Iglesias F; Gonzalez-Alegre T; Fernandez-Puntero B; Cornejo-Del Rio VM; Sanchez-Arroyo V; Sabín-Rodríguez C; López-López S; Gómez-Campelo P; Taulero-Escalera B; Rodriguez-Artalejo F; San Andrés-Rebollo FJ; De Burgos-Lunar C;
    BMJ Open; 2024 Jun; 14(6):e083121. PubMed ID: 38844393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence-a population-based survey of 6898 Han participants from southern China.
    Huang H; Peng G; Lin M; Zhang K; Wang Y; Yang Y; Zuo Z; Chen R; Wang J
    Prev Med; 2013 Oct; 57(4):345-50. PubMed ID: 23777673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population.
    Robinson CA; Agarwal G; Nerenberg K
    Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM; Chia YC; Koay ZL
    Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal hemoglobin A1C cutoff value for diabetes mellitus and pre-diabetes in Pudong New Area, Shanghai, China.
    Zhou X; Ruan X; Hao L; Zhou Y; Gu J; Qiu H; Wu K; Yu S; Rui X; Wang X; Liu X; Ke J; Zhao G; Sun Q
    Prim Care Diabetes; 2018 Jun; 12(3):238-244. PubMed ID: 29370998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel model enhances HbA1c-based diabetes screening using simple anthropometric, anamnestic, and demographic information.
    Cichosz SL; Johansen MD; Ejskjaer N; Hansen TK; Hejlesen OK
    J Diabetes; 2014 Sep; 6(5):478-84. PubMed ID: 24456075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age.
    Guo F; Moellering DR; Garvey WT
    Metab Syndr Relat Disord; 2014 Jun; 12(5):258-68. PubMed ID: 24512556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009.
    Sun X; Du T; Huo R; Xu L
    Acta Diabetol; 2014; 51(3):353-60. PubMed ID: 24072380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.
    Li J; Bergmann A; Reimann M; Bornstein SR; Schwarz PE
    Horm Metab Res; 2009 Feb; 41(2):98-103. PubMed ID: 18975253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study.
    Fokkens BT; van Waateringe RP; Mulder DJ; Wolffenbuttel BHR; Smit AJ
    Diabetes Metab; 2018 Nov; 44(5):424-430. PubMed ID: 29097003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.